🇺🇸 FDA
Patent

US 7566718

Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity

granted A61PA61P1/04A61P17/00

Quick answer

US patent 7566718 (Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity) held by Pharmacopeia Drug Discovery, Inc. expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Pharmacopeia Drug Discovery, Inc.
Grant date
Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
41
CPC classes
A61P, A61P1/04, A61P17/00, A61P17/06, A61P25/00